Elevating Outcomes in Soft Tissue Sarcoma Through Smart Care Pathways
Empowering hospitals, innovators, and investors with integrated tools for diagnosis, resection, reconstruction, and patient recovery.
Elevating Outcomes in Soft Tissue Sarcoma Through Smart Care Pathways
Empowering hospitals, innovators, and investors with integrated tools for diagnosis, resection, reconstruction, and patient recovery.
From Diagnosis to Recovery—Connected, Contextual, and Clinically Informed
Soft tissue sarcomas demand a highly coordinated approach—from early biopsy to wide resection and functional reconstruction. Our approach integrates multi-specialty workflows with real-time patient-reported metrics and imaging-informed interventions. By placing intelligent care coordination at the core, we help teams deliver better outcomes, faster recoveries, and higher operational efficiency.
A comprehensive patient-reported tool evaluating disability, impairment, and handicap in upper or lower extremities following limb salvage surgery for soft tissue tumors.
Provides standardized measures across various health domains (e.g., physical function, pain, fatigue, emotional health) for comparison within and across conditions.
From Diagnosis to Recovery—Connected, Contextual, and Clinically Informed
Soft tissue sarcomas demand a highly coordinated approach—from early biopsy to wide resection and functional reconstruction. Our approach integrates multi-specialty workflows with real-time patient-reported metrics and imaging-informed interventions. By placing intelligent care coordination at the core, we help teams deliver better outcomes, faster recoveries, and higher operational efficiency.
A comprehensive patient-reported tool evaluating disability, impairment, and handicap in upper or lower extremities following limb salvage surgery for soft tissue tumors.
Provides standardized measures across various health domains (e.g., physical function, pain, fatigue, emotional health) for comparison within and across conditions.
Powered suported by leading international healthcare service
Engineering Confidence in Every Cut, Closure, and Reconstruction
Soft tissue sarcoma surgeries often require wide excision, complex reconstruction, and tailored implants. These core components offer structural, functional, and oncologic benefits when precision matters most.
Reconstructive Mesh
Outcome:
Restores tissue integrity with high tensile strength. Reduces recurrence in hernia repairs. Ideal for adults 30–70 with soft tissue defects.
Reconstructive Flaps
Outcome:
Promotes healing, restores function in complex wounds. Minimizes complications in tissue reconstruction. Suits adults 25–65 for reconstructive needs.
Radiation-Compatible Anchoring Devices
Outcome:
Ensures stable fixation during radiation therapy. Maintains integrity under radiation exposure. Optimal for cancer patients 40–80 undergoing treatment.
Modular Endoprostheses
Outcome:
Restores limb function after joint-involving soft tissue sarcoma resection. Ideal for adults 40–80 needing durable joint replacement for mobility.
Expandable Prosthesis
Outcome:
Adapts to growth and stabilizes limb after sarcoma removal, potentially reducing revisions. Suits patients 20–70 needing functional reconstruction.
Why Surgeons, Engineers, and Investors Are Turning to Us
We don’t just support sarcoma care—we enable those shaping its future. Our interoperable tools and data-first approach remove complexity while amplifying impact for every stakeholder involved.
Unifies clinical data and diagnostics
to streamline tumor board decisions and surgical planning.
Supports device integration and testing
in real-world surgical and recovery settings.
Improves follow-up visibility
with longitudinal PROMs and imaging insights in one place.
Reduces variability in care
by guiding teams with standardized, adaptable protocols for rare tumor types.
Accelerates clinical validation
for novel implants and imaging tools via built-in data capture modules.
Improves financial clarity
through outcome-based resource tracking and reporting across episodes of care.
Expands market value
with adaptable applications across sarcoma subtypes and other soft tissue malignancies.
Drives investor confidence
with measurable performance, patient impact, and health system integration.
Let’s Transform Soft Tissue Sarcoma Care
From first scan to final outcome, we’re enabling what comes next in cancer care innovation.
